China Pharma Holdings
CPHI
5 hedge funds and large institutions have $45.4K invested in China Pharma Holdings in 2023 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 3 increasing their positions, 1 reducing their positions, and 1 closing their positions.
200% more repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 1
0.02% more ownership
Funds ownership: 0.03% → 0.05% (+0.02%)
15% less capital invested
Capital invested by funds: $53.1K → $45.4K (-$7.71K)
17% less funds holding
Funds holding: 6 → 5 (-1)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 1
Top Buyers
| 1 |
VF
Virtu Financial
New York
|
+$23.2K |
| 2 |
Millennium Management
New York
|
+$14.6K |
| 3 |
TSS
Two Sigma Securities
New York
|
+$10.1K |
Top Sellers
| 1 |
Renaissance Technologies
New York
|
-$8.01K |
| 2 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
-$4.95K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
VF
1
Virtu Financial
New York
| $17K | +$23.2K | +1,910 | +448% |
|
|
2
Millennium Management
New York
| $14.3K | +$14.6K | +1,203 | +164% |
|
|
TSS
3
Two Sigma Securities
New York
| $9.01K | +$10.1K | +833 | +217% |
|
|
4
Renaissance Technologies
New York
| $5K | -$8.01K | -658 | -52% |
|
|
FCT
5
First Community Trust
Dubuque,
Iowa
| $22 | – | – | – |
|
|
BCM
6
Bridgeway Capital Management
Houston,
Texas
| – | -$4.95K | -290 | Closed |
|
CPHI Hedge Fund Activity: Q3 2023 in Review
5 of the 6,301 institutional investors tracked by Wall St. Rank reported a position in China Pharma Holdings (CPHI) for Q3 2023, worth a combined $45.4K — down 15% from $53.1K a quarter earlier.
Sellers outnumbered buyers: 1 fund closed out of CPHI and 0 opened new positions — a net loss of 1 holder — while 1 trimmed existing stakes and 3 added.
The largest buyer was Virtu Financial, adding an estimated $23.2K. The largest seller was Renaissance Technologies, cutting an estimated $8.01K.
- 5 institutional investors held China Pharma Holdings (CPHI) as of Q3 2023, down from 6 in Q2 2023.
- Funds reported $45.4K of China Pharma Holdings stock for Q3 2023, down 15% quarter-over-quarter.
- 0 funds opened new China Pharma Holdings positions in Q3 2023 and 1 closed out, a net change of -1 holder.
- The largest China Pharma Holdings buyer in Q3 2023 was Virtu Financial, an estimated $23.2K added.
- The largest China Pharma Holdings seller in Q3 2023 was Renaissance Technologies, an estimated $8.01K sold.
Based on aggregated 13F filings for Q3 2023.